Daily Laparoscopic and Robotic Surgery News Digest

29 May 2026

Nationwide Japanese Registry Demonstrates Short-Term Advantages of Robotic Distal Gastrectomy Over Laparoscopic Distal Gastrectomy

A major contemporary analysis from Japan provides one of the largest real-world comparisons of robotic and laparoscopic gastrectomy for gastric cancer performed in a mature national robotic surgery environment. The study, published in Gastric Cancer and indexed in PubMed, evaluated outcomes from the Japanese National Clinical Database between January 2023 and December 2024, a period during which robotic gastric surgery had already become established across many high-volume centers.

The investigators performed a retrospective propensity-score matched analysis comparing robotic distal gastrectomy (RDG) with laparoscopic distal gastrectomy (LDG), and robotic total gastrectomy (RTG) with laparoscopic total gastrectomy (LTG). After rigorous matching to minimize selection bias, the study analyzed 9,743 matched pairs for distal gastrectomy and 1,617 matched pairs for total gastrectomy, making it one of the largest comparative studies available in gastric cancer surgery.

The findings suggest that robotic technology may now be delivering measurable clinical benefits in distal gastrectomy. Patients undergoing robotic distal gastrectomy experienced a statistically significant reduction in serious postoperative complications defined as Clavien-Dindo grade IIIa or higher within 30 days of surgery. The complication rate was 4.3% in the robotic group compared with 4.9% in the laparoscopic group. Although the absolute difference appears small, the significance becomes important when applied across thousands of procedures performed annually in a national healthcare system.

Additional perioperative advantages were also observed. Robotic distal gastrectomy demonstrated lower intraoperative blood loss, reduced conversion to open surgery, fewer intra-abdominal infectious complications, and shorter postoperative hospitalization. These improvements are clinically relevant because conversion and postoperative infections are among the most important factors influencing recovery, resource utilization, patient satisfaction, and overall healthcare costs.

The authors propose that enhanced instrument articulation, tremor filtration, stable three-dimensional visualization, and improved ergonomics may contribute to more precise dissection around major vascular structures and lymphatic tissue. Gastric cancer surgery often requires meticulous lymphadenectomy in confined anatomical spaces, particularly around the celiac axis, common hepatic artery, splenic artery, and left gastric artery. The robotic platform may provide technical advantages during these demanding portions of the operation.

One notable observation was that operative time remained longer in the robotic distal gastrectomy cohort. This finding has been consistently reported in previous robotic surgery literature and likely reflects docking requirements, robotic setup, and the technical complexity of robotic procedures. However, as experience grows and workflow improves, many centers have reported progressive reductions in operative duration over time.

The picture was different for total gastrectomy. Although robotic total gastrectomy showed lower blood loss, fewer conversions to open surgery, and shorter hospital stay, it did not demonstrate a statistically significant reduction in the primary endpoint of major postoperative morbidity compared with laparoscopic total gastrectomy. Major complication rates were 8.7% for robotic surgery and 8.3% for laparoscopic surgery.

This distinction is important because total gastrectomy remains one of the most technically demanding procedures in upper gastrointestinal surgery. Reconstruction following total gastrectomy, particularly esophagojejunostomy creation, remains challenging even with robotic assistance. The complexity of mediastinal dissection, reconstruction, and management of anastomotic risks may limit the magnitude of benefit currently achievable through robotic technology.

For surgeons and hospital administrators, the study provides valuable contemporary benchmarking data. The findings support the view that robotic distal gastrectomy has moved beyond the experimental phase and may now offer tangible short-term clinical advantages when performed within an experienced robotic program. These benefits may justify investment in robotic platforms in centers with sufficient procedural volume and expertise.

However, the study should not be interpreted as definitive proof that robotic surgery is universally superior. The analysis remains observational despite sophisticated statistical matching. Important variables such as surgeon experience, institutional volume, patient selection, and unmeasured confounding factors cannot be completely eliminated. Randomized controlled trials would still provide the highest level of evidence.

The results nevertheless align with a growing body of literature suggesting that the benefits of robotic surgery are most apparent in procedures requiring precise dissection within narrow anatomical spaces and extensive lymph node clearance. Gastric cancer surgery, particularly distal gastrectomy with D2 lymphadenectomy, appears to fit this profile well.

Another practical implication concerns surgical training. The study demonstrates outcome benchmarks that training programs can use when evaluating the adoption of robotic gastric surgery. As robotic systems become increasingly integrated into upper gastrointestinal surgical practice, structured training pathways will be necessary to ensure that outcome improvements seen in high-volume Japanese centers can be reproduced elsewhere.

From a patient counseling perspective, surgeons can reasonably discuss the potential for lower blood loss, reduced conversion rates, fewer infectious complications, and shorter hospitalization when considering robotic distal gastrectomy. At the same time, patients should understand that robotic surgery remains associated with longer operating times and that long-term oncologic superiority has not yet been established.

Overall, this nationwide Japanese registry analysis represents some of the strongest contemporary evidence supporting robotic distal gastrectomy. The study suggests that robotic technology may now be translating technical advantages into measurable patient benefits in routine clinical practice. In contrast, robotic total gastrectomy continues to show perioperative advantages without a corresponding reduction in major complications, highlighting the ongoing challenges associated with more complex gastric cancer procedures.

Relevance for Laparoscopic and Robotic Surgeons

This study is highly relevant for surgeons involved in gastric cancer treatment, robotic program development, and minimally invasive surgical training. It provides contemporary real-world evidence that robotic distal gastrectomy may reduce serious complications, conversions, blood loss, and postoperative infectious events compared with conventional laparoscopy. The findings may influence platform selection, credentialing pathways, institutional investment decisions, patient counseling, and future training curricula. For centers considering expansion of robotic upper-GI services, the data suggest that distal gastrectomy may currently represent the procedure where robotic benefits are most consistently demonstrated.

Source

PubMed:
https://pubmed.ncbi.nlm.nih.gov/42189454/

Clinical advantages of robotic gastrectomy for gastric cancer over conventional laparoscopic approach: a retrospective cohort study using a nationwide registry database in Japan